We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Arming Platelets to Deliver Cancer Immunotherapy

News   Jan 25, 2017 | Original story from UNC Health Care

 
Arming Platelets to Deliver Cancer Immunotherapy

Zhen Gu, PhD. Photo courtesy of UNC-NC State Joint Biomedical Engineering Program

 
 
 

RELATED ARTICLES

Clinical Trial of Antiviral Drug To Treat Coronavirus Begins

News

A randomized, controlled clinical trial to evaluate the safety and efficacy of the investigational antiviral remdesivir in hospitalized adults diagnosed with coronavirus disease 2019 (COVID-19) has begun at the University of Nebraska Medical Center (UNMC) in Omaha.

READ MORE

Antibody Equals Antidepressant?

News

Researchers have discovered that the level of NMDA receptor autoantibodies in the blood can increase with chronic stress, potentially acting as a self-produced antidepressant.

READ MORE

Team Designs Tiny Nanoparticles To Target Cancer Cells

News

Scientists have designed tiny nanoparticles that can specifically navigate to, and target, cancer cells.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE